Found: 33
Select item for more details and to access through your institution.
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Erratum: Tanvetyanon T. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer. 2005; 103(2):237–41.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2530
- Publication type:
- Article
Phase II study of temozolomide plus pegylated interferon‐α‐2b for metastatic melanomaPresented in part at the 39th American Society of Clinical Oncology Annual Meeting in New Orleans, Louisiana, June 5‐8, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2445
- By:
- Publication type:
- Article
Once daily, oral, outpatient quinolone monotherapy for low‐risk cancer patients with fever and neutropeniaThese data were presented in part as abstract 375 at the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9‐12, 2003.: A pilot study of 40 patients based on validated risk‐prediction rules
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2489
- By:
- Publication type:
- Article
Generalizability of cancer clinical trial resultsPresented in part at the 38th Annual Meeting of the American Society of Clinical Oncology, May 18‐21, 2002, Orlando, Florida.The funding entities were not involved in the design or conduct of the study, analysis of results, interpretation of findings, or preparation of this report.: Prognostic differences between participants and nonparticipants
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2452
- By:
- Publication type:
- Article
Randomized trial of high‐dose chemotherapy and autologous hematopoietic stem cell support for high‐risk primary breast carcinoma: Follow‐up at 12 years.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2327
- By:
- Publication type:
- Article
Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5‐Aza‐2′‐deoxycytidine.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2514
- By:
- Publication type:
- Article
Author reply.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2529
- By:
- Publication type:
- Article
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2528
- By:
- Publication type:
- Article
A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemiaData management and statistical analyses were performed by Hans Garmo and Gunilla Juhlin at the regional Oncologic Center in Uppsala, Sweden.: Feasibility, clinical and biologic effects, and impact on quality of life
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2397
- By:
- Publication type:
- Article
Characteristics of patients and predictors of in‐hospital mortality after hospitalization for head and neck cancers.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2382
- By:
- Publication type:
- Article
High‐risk cutaneous squamous cell carcinoma of the head and neckPresented as an oral presentation at the 56th Annual Scientific Meeting of the Royal Australian and New Zealand College of Radiologists, Sydney, Australia, October 6–9, 2005.: Results from 266 treated patients with metastatic lymph node disease
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2389
- By:
- Publication type:
- Article
Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2363
- By:
- Publication type:
- Article
Quality of life in long‐term survivors of bladder cancer.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2355
- By:
- Publication type:
- Article
Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomyPresented in part at the American Urological Association Meeting, San Antonio, Texas, May 21–26, 2005.This original study received the American Society of Clinical Oncology's Merit Award at the Prostate Cancer Symposium, 2005.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2369
- By:
- Publication type:
- Article
Patterns and predictors of mammography utilization among breast cancer survivors.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2482
- By:
- Publication type:
- Article
Impact of age on outcome of pediatric acute myeloid leukemiaPresented in part at the 46th Annual Meeting of the American Society of Hematology, December 5, 2004, San Diego, CA.: A report from 2 institutions.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2495
- By:
- Publication type:
- Article
Estrogen‐based hormone therapy and thrombosis risk in women with essential thrombocythemia.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2406
- By:
- Publication type:
- Article
Volume and process of care in high‐risk cancer surgeryThe views expressed herein do not necessarily represent the views of Center for Medicare and Medicaid Services or the US Government.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2476
- By:
- Publication type:
- Article
The “y” symbol: An important classification tool for neoadjuvant cancer treatment.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2526
- By:
- Publication type:
- Article
Benefit of taxanes as adjuvant chemotherapy for early breast cancerPresented as a Poster Discussion at the European Cancer Conference (ECCO), Paris, France, October 30th to November 3rd, 2005.: Pooled analysis of 15,500 patients.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2337
- By:
- Publication type:
- Article
Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum‐based chemotherapy in advanced nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2421
- By:
- Publication type:
- Article
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2428
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2412
- By:
- Publication type:
- Article
Dietary selenium intake, aldehyde dehydrogenase‐2 and X‐ray repair cross‐complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2345
- By:
- Publication type:
- Article
Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2459
- By:
- Publication type:
- Article
Health insurance coverage and cost barriers to needed medical care among U.S. adult cancer survivors age <65 yearsThe findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agency.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2466
- By:
- Publication type:
- Article
Association between adiponectin, insulin resistance, and endometrial cancer.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2376
- By:
- Publication type:
- Article
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2318
- By:
- Publication type:
- Article
Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanomaPresented in part at the 2005 Annual Meeting of the American Society of Clinical Oncology.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2437
- By:
- Publication type:
- Article
Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trialThis article is a US Government work and, as such, is in the public domain in the United States of America.The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2309
- By:
- Publication type:
- Article